These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21289971)

  • 21. Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany.
    Sroczynski G; Schnell-Inderst P; Mühlberger N; Lang K; Aidelsburger P; Wasem J; Mittendorf T; Engel J; Hillemanns P; Petry KU; Krämer A; Siebert U
    GMS Health Technol Assess; 2010 Apr; 6():Doc05. PubMed ID: 21289878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of portable-automated ABR for universal neonatal hearing screening in India.
    Sahoo KC; Dwivedi R; Athe R; Chauhan A; Jain S; Sahoo RK; Bhattacharya D; Rajsekhar K; Pati S
    Front Public Health; 2024; 12():1364226. PubMed ID: 39188791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The frequency of auditory neuropathy detected by universal newborn hearing screening program.
    Kirkim G; Serbetcioglu B; Erdag TK; Ceryan K
    Int J Pediatr Otorhinolaryngol; 2008 Oct; 72(10):1461-9. PubMed ID: 18674822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild-moderate congenital hearing loss: secular trends in outcomes across four systems of detection.
    Carew P; Mensah FK; Rance G; Flynn T; Poulakis Z; Wake M
    Child Care Health Dev; 2018 Jan; 44(1):71-82. PubMed ID: 28612343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of long-term impacts of universal newborn hearing screening.
    Chiou ST; Lung HL; Chen LS; Yen AM; Fann JC; Chiu SY; Chen HH
    Int J Audiol; 2017 Jan; 56(1):46-52. PubMed ID: 27598544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The economics of screening infants at risk of hearing impairment: an international analysis.
    Burke MJ; Shenton RC; Taylor MJ
    Int J Pediatr Otorhinolaryngol; 2012 Feb; 76(2):212-8. PubMed ID: 22129917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease.
    Müller-Riemenschneider F; Damm K; Meinhard C; Bockelbrink A; Vauth C; Willich SN; Greiner W
    GMS Health Technol Assess; 2009 Dec; 5():Doc16. PubMed ID: 21289903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newborn Hearing Screening: Analysing the Effectiveness of Early Detection of Neonatal Hearing Loss in a Hospital in Greece.
    Kosmidou P; Tzifas S; Lygeros S; Danielides G; Nikolopoulos T; Dimitriou G; Angelis S; Naxakis S
    Cureus; 2021 Nov; 13(11):e19807. PubMed ID: 34956791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost-effectiveness of tracking newborns with bilateral hearing impairment in Bavaria: a decision-analytic model.
    Langer A; Brockow I; Nennstiel-Ratzel U; Menn P
    BMC Health Serv Res; 2012 Nov; 12():418. PubMed ID: 23170955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter evaluation of how many infants with permanent hearing loss pass a two-stage otoacoustic emissions/automated auditory brainstem response newborn hearing screening protocol.
    Johnson JL; White KR; Widen JE; Gravel JS; James M; Kennalley T; Maxon AB; Spivak L; Sullivan-Mahoney M; Vohr BR; Weirather Y; Holstrum J
    Pediatrics; 2005 Sep; 116(3):663-72. PubMed ID: 16140706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cost-effectiveness analysis of newborn hearing screening strategies.
    Kemper AR; Downs SM
    Arch Pediatr Adolesc Med; 2000 May; 154(5):484-8. PubMed ID: 10807300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen.
    Bamford J; Fortnum H; Bristow K; Smith J; Vamvakas G; Davies L; Taylor R; Watkin P; Fonseca S; Davis A; Hind S
    Health Technol Assess; 2007 Aug; 11(32):1-168, iii-iv. PubMed ID: 17683682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of Universal Newborn Screening Programs: Systematic Review.
    Yoshinaga-Itano C; Manchaiah V; Hunnicutt C
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34202909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection.
    Gantt S; Dionne F; Kozak FK; Goshen O; Goldfarb DM; Park AH; Boppana SB; Fowler K
    JAMA Pediatr; 2016 Dec; 170(12):1173-1180. PubMed ID: 27723885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Universal hearing screening in the Champagne-Ardenne regions: results and consideration after 55 000 births from January 2004 to June 2007].
    Langagne T; Schmidt P; Leveque M; Chays A
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(3):153-8. PubMed ID: 19694157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.